Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Been watching this too, recently - this down trend is a lil' concerning though - shorts and/or dilution. It seems to go up a little, to only fall back, again. Did you see this, in a prior post?
are they also expecting news soon? I've been watching and picked up some here... looks pretty good
yep.. moving on up. lots of short positions. could bounce hard.
starting to move now
cthp gettin some volume into the close?
Ive been loading here also Big... glty bbilly
What iHub means by those stats are as follows: "Buy" is a trade at the ask. "Sell" is a trade at the bid.
Again, anyone buying at the ask is buying shares from another person who is selling at the ask. Anybody who is selling at the bid is selling those shares to a buyer at the bid. So technically, there are just as many buys as sells. iHub is only distinguishing how many take place at the bid vs. the ask.
The ask / bid goes down if there are more people TRYING to sell than there are people willing to buy at that price. So, the MM's move the ask down, and down, and down, until it hits a price where there are buyers willing to pick up the shares from the would-be sellers.
Likewise, the price goes up if there are more people wanting to buy than there are people trying to sell. As the price rises, more willing sellers emerge.
It is simply supply vs. demand. I'm sure you know this though...so sorry for my long-winded reply. As for me, I hope there are a LOT more willing buyers tomorrow so the price can go back up
If you hit the "trades" button on IHUB, you'll be able to see what were buys and what were sells and what price they were at. Anytime some buys above the ask, the stock goes up. Anytime some sells at ask (if the ask is higher than the bid), then the price goes up.
Technically, CTHP is upgraded to buy today with the $0.055 target price in six months.
Check here:
"http://www.allotcbb.com/quote.php?symbol=cthp"
Looks like we're going to fill the gap from this morning.
Going to .0136
Then hopefully we can turn it back up again for a few days
Don't know where you get that number from.
There are plenty of sells today as well. Remember, this is stock trading, so every sell is also a buy and vice versa. If you mean "sells" to be at the bid, and "buys" to be at the ask, there are many sells at the bid. That's why the price is going down from the high...because there are more trades at the bid than at the ask.
I'm still holding my shares. I like this stock...but just thought it was odd to see you say that there are only 2 sells today. hehe
This definently looks worth watching.
Out of 82 trades today, only 2 have been sells! Lot of people buying in...
CTHP 's going up to 6 cents+ at least soon!
Good for hold and set prices high!
Already some buyers pre-market, this thing could have a monster day going here!
Yes it is, and correct also. Looks like the bounce will continue nicely.
Sweeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeettttt!!
2 guys had a heap of stock and wanted out, they are gone, that I know!
hey a question for the mod on this one, is it legit to not only talk about CTHP but the post made on here, or the history of peoples post???
My guess someone decided to sell shares slowly. Thats the usual case anyways now the seller is gone and the stock is headed back up higher
Hey guys.....why the big crash last month?
Looking good for sure moved up 26% on just under 3 mill in volume. Ask is super thin. I would bet 5 mill day would send it up over 2 cents
I only need 50,000 more to finish up my holdings.
Good Morning! Thanks for the explaination!
Jenners
Sweet niblets, close at HOD, will be interesting next week to see how high this one goes.
I agree Epic, Monday and Tuesday will be huge!
one left @ .0136 ... gonna be a great week ahead, IMO.
Cheers!
CTHP first day of pinch will hit many scans over the weekend . Pinchers usually pop for 3 days with the second and third days being the highest gains
This thing is finding it's legs, next week could be a big week for this one!
Thats ADX & PPO
Indeed..nice call on the bounce folks
CTHP --- The only way is up! Quickly get in!
We all set prices high!
I see said the blind man to the deaf dog...thank you
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
324
|
Created
|
06/09/09
|
Type
|
Free
|
Moderators |
Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize. The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. CTI seeks partners to co-develop drugs in various stages in our pipeline.
CTI’s first investment under this strategy is NanoTherapies LLC. Nano’s products introduce disruptive technology into the treatment and detection of cancer through the use of calcium phosphate nanoparticles. These particles, about 350 times smaller than a human cell, provide both a safe and effective way to transport drugs and imaging materials into diseased cells. The compatibility of the calcium phosphate nanoparticle with the biomechanics of the human body makes it unique for application in the treatment of diseases. Patient benefits from drugs jacketed with calcium phosphate nanoparticles are immense.
The development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. NanoTherapies has sole license and patent protection for the fundamental use of calcium phosphate nanoparticles in medical applications for the treatment and detection of blood cancers (all forms of leukemia). Nano also owns all rights to manufacturing technologies and patents required to produce pharmaceutical quality drugs at the scale and yield needed for commercial viability.
Four drugs have been identified for accelerated market delivery and early revenue: Methotrexate, Cytarabine, Fludarabine and Daunorubicin. Cerimide-based drugs and a newly discovered Amplified Photon Emission Therapy (APET) also comprise part of the product portfolio, but will require longer clinical trials to get to market.
Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize. The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. CTI seeks partners to co-develop drugs in various stages in our pipeline.
CTI’s first investment under this strategy is NanoTherapies LLC. Nano’s products introduce disruptive technology into the treatment and detection of cancer through the use of calcium phosphate nanoparticles. These particles, about 350 times smaller than a human cell, provide both a safe and effective way to transport drugs and imaging materials into diseased cells. The compatibility of the calcium phosphate nanoparticle with the biomechanics of the human body makes it unique for application in the treatment of diseases. Patient benefits from drugs jacketed with calcium phosphate nanoparticles are immense.
The development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. NanoTherapies has sole license and patent protection for the fundamental use of calcium phosphate nanoparticles in medical applications for the treatment and detection of blood cancers (all forms of leukemia). Nano also owns all rights to manufacturing technologies and patents required to produce pharmaceutical quality drugs at the scale and yield needed for commercial viability.
Four drugs have been identified for accelerated market delivery and early revenue: Methotrexate, Cytarabine, Fludarabine and Daunorubicin. Cerimide-based drugs and a newly discovered Amplified Photon Emission Therapy (APET) also comprise part of the product portfolio, but will require longer clinical trials to get to market.
Cancer Therapeutics will be in a position to engage high level personnel and intellectual capital from NanoTherapies to evaluate other synergistic investment opportunities. CTI will then pursue the most promising and valuable technologies to reach the market expeditiously and benefit the lives of cancer patients worldwide.
Cancer Therapeutics Inc is a Delaware corporation. CTI’s Common Stock is listed on the NASD Electronic Bulletin Board under the symbol “CTHP.” The Company’s stock has been traded on the Bulletin Board since March, 2007.
Cancer Therapeutics Inc is located in South Jordan (Salt Lake City), Utah.
Cancer Therapeutics Inc
10757 S. River Front Pkwy.
Suite 125
South Jordan, Utah 84095
Telephone (801) 816-2533
Facsimile (801) 816-2599
Email
Chene Gardner
President, Chief Executive Officer, Chief Financial Officer
John D. Thomas
General Counsel
Outstanding Shares: 85,541,266 as of Sep 07, 2010
The information contained within this iBox including web links, copied information, and any other associated messages/media (hereinafter collectively referred to as "Information") is provided for informational purposes only. The Information should not be construed as investment/trading advice and is not meant to be a solicitation or recommendation to buy, sell, or hold Cancer Therapeutics, Inc. (CTHP) stock.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |